Radar › Companies › Healthcare · North Rhine Westphalia
Radar · Healthcare in North Rhine Westphalia

Best Healthcare Companies in North Rhine Westphalia, Germany

The 203 best Healthcare companies in North Rhine Westphalia, Germany in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Gerresheimer.

203companies tracked
$582.1Mdisclosed funding
0unicorns
21have raised

Ranked: Best Healthcare companies in North Rhine Westphalia

#CompanyDisclosed fundingLast roundEmployeesFounderTech stackWeb popularityPatents & IP focusRecent signals
1A & M Group
GLP bioanalytical and cGMP analytical testing services for drug development
——278Hartmut Fischer
Co-Founder
WordPressPleskApple iCloud Mail+21Top 10M——
2Adler
Standalone drug store
———Oliver Korsten
Founder
————
3Adler-Apotheke am Klinikum
Standalone pharmacy
———Sabine Schoening
Owner
SentryApple iCloud MailAmazon Web Services+11Top 50M——
4Admedicum
Patient-focused healthcare company that specializes in patient engagement and access solutions, helping to…
————WordPressMySQLPHP+18Top 50M——
5Advanced Defense Technologies
Manufacturer of protective equipment and test kits services
———Kevin Abu-Majd
CEO
————
6aerobis fitness
Manufacturer of diversified fitness equipments
————Cart FunctionalityShopifySentry+31Top 5M5 patents
Cable and elastic resistance training equipment for strength and fitness exercises
—
7Aircontrols
Manufacturer of gas dosing, respiratory therapy or ventilation systems
———Volker Sauerbaum
CEO
——11 patents
Medical gas mixing, flow measurement, and composition analysis for patient ventilation systems.
—
8Alexianer
Health system
——1,124—————

Top 12 Healthcare companies in North Rhine Westphalia

#1
Seed · Aachen, North Rhine Westphalia · founded 2022
$5.8Mraised
▾

Developer of organ preservation solutions for use in labs. The company offer solutions like Vivalyx Omnisol a blood-free preservation solution for all organ preservation methods, including cold and warm perfusion as well as static cold storage, with expected beneficial clinical outcomes.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 1k LinkedIn followers
Activity: 3 awards announced in 12 mo
Funding rounds
  • Apr 2024Seed$5.8M
Founders & team
Benedict DoorschodtChief Technology Officer & Co-FounderRené TolbaFounder And Chief Medical OfficerChristian BleilevensChief Scientific Officer & Co-Founder
Investors
TechVision Fonds, Brightlands Venture Partners, Arve Capital, GOOSE Capital, Springboard Health Angels
#2
Acquired · Dusseldorf, North Rhine Westphalia · founded 1864 · 350 employees
$457.1Mraised
▾

Manufacturer of primary packaging products for medication and drug delivery devices. Company specializes in the production of drug packaging and delivery systems, with basis on glass and plastic packaging solutions for the pharmaceutical, health, well-being, and biotech industries. It offers prefillable syringes and cartridges made of glass or plastic.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 111k LinkedIn followers
Activity: 1 awards announced in 12 mo
Founders & team
Fred HoweryPresident & CEO/Senior Site Director
Investors
Quest for Growth, Investcorp, Aheim
Tech stack
Apache Http ServerApple Icloud MailCalendlyCart FunctionalityCloudflareDocusign
#3
Public · Aachen, North Rhine Westphalia · founded 2000 · 51 employees
$47.7Mraised
▾

Paion is specialised in developing drugs for the hospital-based treatment of central nervous system (CNS) disorders and thrombotic/cardiovascular diseases. Its drug pipeline include Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anaesthetic for anaesthesia (Phase 3) and for procedural sedation (Phase 3); Morphine-6-glucuronide (M6G), a pharmacologically active metabolite of morphine, is suitable for the treatment of post-operative pain (Phase 3); GGF2 (Glial Growth Factor 2) for heart failure (Phase 1). Paion is not actively involved in the development of GGF2 and M6G, but instead benefits from future milestone payments and royalties. GGF2 is developed by Acorda Therapeutics, and M6G is developed by Yichang Humanwell.

Funding rounds
  • Jul 2017Post IPO$9.2M
  • Jun 2016Post IPO$10.6M
  • Jul 2014Post IPO$6.7M
  • Jul 2014Post IPO$5.4M
Investors
Cosmo Pharmaceuticals, 3i Group, NeoMed, Creathor Venture, Endeavour Vision, Omega Funds
Tech stack
Apple Icloud MailBootstrapDocusignHammer.JsJqueryMicrosoft 365
#4
Series A · Dortmund, North Rhine Westphalia · founded 2014 · 71 employees
$5.2Mraised
▾

Provider of dental aligner manufacturing and private label services

LinkedIn Pulse recent public activity · Jul 2026
Audience: 11k LinkedIn followers
Funding rounds
  • Oct 2022Series A$5.2M
Founders & team
Sherif KandilCo-Founder & CEO
Investors
Maki, Nordic Seed
#5
Late Stage · Minden, North Rhine Westphalia · founded 1949 · 1918 employees
$52.9Mraised
▾

Healthcare systems

Investors
HHS, HealthCap
Tech stack
Amazon ElbAmazon Web ServicesAutoptimizeBabelBootstrapCart Functionality
#6
Seed · Munster, North Rhine Westphalia · founded 2019 · 11 employees
$2.9Mraised
▾

Refined Laser Systems: Revolutionizing cancer diagnostics with innovative laser technology. This dynamic biophotonics company develops cutting-edge laser systems for stain-free, section-free tissue diagnostics. Their technology enables rapid, accurate identification of cancer cells directly from thick specimens, eliminating the need for time-consuming traditional methods. This significantly reduces the time required for diagnosis, allowing for faster treatment decisions and improved patient outcomes. The company's solutions are designed to empower surgeons and pathologists, providing clear insights into tissue and cell systems within minutes. Their commitment to innovation and impact drives them to continuously improve their products and services, ultimately aiming to make a meaningful difference in cancer care. The technology is based on coherent Raman scattering microscopy, a label-free imaging technique that provides high-contrast images comparable to traditional H&E staining. The company is dedicated to improving the lives of patients and healthcare professionals alike.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers
Activity: 1 product launches announced in 12 mo
Funding rounds
  • Jan 2023Seed$2.9M
Founders & team
Christopher SeidenstuckerCo-Founder
Investors
HTGF, APEX Ventures, NRW.Bank, Onsight Ventures, PAPST INVEST, OHA
#7
Series A · Cologne, North Rhine Westphalia · founded 2010 · 14 employees
$4.7Mraised
▾

Developer of in-vitro diagnostic products for acute and critical care conditions in newborns. The product HypoxE test is used for the early identification of newborns suffering from perinatal asphyxia due to oxygen deficit during birth, the prognosis of hypoxic-ischemic encephalopathy, and brain injuries.

Funding rounds
  • Mar 2022Series A—
  • Jul 2021Series A$4.7M
Investors
Alluti, FIL Bros. Capital GmbH
#8
Funding Raised · Hagen, North Rhine Westphalia · founded 1996
$1.5Mraised
▾

ZEUS GmbH is a research center focused on applied psychology, environmental, and social research. The company conducts studies and provides expertise on environmental noise, noise pollution, and its impact on human health and well-being. ZEUS GmbH also offers consulting services and collaborates with other organizations to develop innovative solutions for noise assessment and management.

Funding rounds
  • Jan 2020Grant (prize money)$596K
  • Nov 2017Grant (prize money)$191.9K
  • Oct 2017Grant (prize money)$748.6K
  • Dec 2016Grant (prize money)—
Founders & team
Dirk SchreckenbergManaging Director
Investors
Europa
#9
Funding Raised · Dusseldorf, North Rhine Westphalia · founded 2014
$980.1Kraised
▾

IXP is a research institute specializing in experimental psychophysiology, conducting cutting-edge studies on human perception, cognition, and behavior. The institute's research focuses on developing innovative methods and technologies to improve well-being, performance, and quality of life. IXP's expertise spans a range of areas, including psychological methods, computer vision, and intelligent textile sensor technology.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 617 LinkedIn followers
Funding rounds
  • Jan 2021Grant (prize money)$742K
  • Jan 2016Grant (prize money)$238.1K
Founders & team
Jarek KrajewskiCo-FounderSebastian SchniederCo-Founder & CEO
Investors
Europa
#10
Funding Raised · Dortmund, North Rhine Westphalia · founded 2001 · 11 employees
$1.4Mraised
▾

Chimera Biotec has developed a proprietary immunoassay platform called Imperacer for ultra-sensitive large molecule bioanalysis. The company claims to be the world's leading Immuno-PCR (IPCR) based technology vendor. The company's products include the Imperacer Workstation, Assay Development Kits and maintenance kit. Services offered include assay development, method validation, and bioanalysis.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 3k LinkedIn followers
Funding rounds
  • Sep 2016Grant (prize money)$225K
  • Mar 2016Grant (prize money)$75K
  • May 2015Grant (prize money)$918.9K
  • Apr 2015Grant (prize money)$226.3K
Founders & team
Mark SpenglerCEO
Investors
Europa, HHS
Tech stack
Apache Http ServerBootstrapCore-JsFont AwesomeGoogle Tag ManagerJquery
#11
Funding Raised · Neuss, North Rhine Westphalia · founded 1999 · 201 employees
$226.4Kraised
▾

Provider of clinical research services for diabetes and obesity studies. The organization conducts pharmacodynamic, pharmacokinetic, biosimilar, safety, and tolerability studies. It also performs bridging studies. The organization offers expertise in developing treatments for diabetes mellitus type 1 and type 2.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 5k LinkedIn followers
Activity: 3 expansions announced in 12 mo
Funding rounds
  • Dec 2021Grant (prize money)$216.4K
  • Sep 2012Grant (prize money)$10K
Founders & team
Med Leona Plum-MörschelChief Executive Officer
Investors
Europa, Land
Tech stack
BootstrapCloudflareCloudflare Bot ManagementGoogle AnalyticsHstsHttp/3
#12
Funding Raised · Dortmund, North Rhine Westphalia · founded 1999 · 61 employees
$572.8Kraised
▾

Provider of drug discovery services

LinkedIn Pulse recent public activity · Jul 2026
Audience: 6k LinkedIn followers
Funding rounds
  • Nov 2018Grant (prize money)—
  • Feb 2016Grant (prize money)$271.5K
  • Jan 2015Grant (prize money)$301.3K
Tech stack
Apache Http ServerAstraCart FunctionalityElementorJqueryJquery Migrate

Funding & investor landscape

$582.1Mtotal disclosed funding
15companies funded
31disclosed rounds
0rounds last 90 days
Most active investors
Europa9 rounds
HHS5 rounds
Deutsche Beteiligungs3 rounds
Digital Pharma Lab2 rounds
Droege Group2 rounds
Invision2 rounds
TechVision Fonds2 rounds
WOLFMAN.ONE2 rounds
360ventures1 rounds
3i Group1 rounds

Notable founders

Benedict Doorschodt
Chief Technology Officer & Co-Founder · Vivalyx
René Tolba
Founder And Chief Medical Officer · Vivalyx
Fred Howery
President & CEO/Senior Site Director · Gerresheimer
Sherif Kandil
Co-Founder & CEO · K Line
Christopher Seidenstucker
Co-Founder · Refined Laser Systems
Dirk Schreckenberg
Managing Director · ZEUS
Jarek Krajewski
Co-Founder · IXP
Sebastian Schnieder
Co-Founder & CEO · IXP
Mark Spengler
CEO · Chimera Biotec
Med Leona Plum-Mörschel
Chief Executive Officer · Profil
Oana Braun
Founder & MD · acromion
Margrit Fooke
CEO · Dr Fooke Laboratorien
Prism market signals · Germany · country-scoped Prism corpus, 2,149,507 docs

Market landscape — 10 sub-themes by coverage

Share of Healthcare coverage by sub-theme.

Regulatory-risk over time rising

Funding & growth over time

funding rising · growth rising

Common questions

How many Healthcare companies are there in North Rhine Westphalia, Germany?
Radar tracks 203 indexable Healthcare companies headquartered in North Rhine Westphalia, Germany that meet our profile-completeness bar.
What is the total funding raised by Healthcare companies in North Rhine Westphalia, Germany?
The Healthcare companies in North Rhine Westphalia, Germany on this list have raised a combined $582.1M in disclosed equity funding across 15 funded companies.
Which is the highest-funded Healthcare company in North Rhine Westphalia, Germany?
Gerresheimer is the highest-funded Healthcare company in North Rhine Westphalia, Germany, with $457.1M in disclosed equity funding.
How many Healthcare companies in North Rhine Westphalia, Germany are funded?
15 of the 203 Healthcare companies in North Rhine Westphalia, Germany on this list have disclosed at least one equity funding round.
How many Healthcare unicorns are there in North Rhine Westphalia, Germany?
None of the Healthcare companies in North Rhine Westphalia, Germany on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in North Rhine Westphalia, Germany Healthcare companies?
The most active investors in North Rhine Westphalia, Germany Healthcare companies on this list include Europa, HHS, Deutsche Beteiligungs, Digital Pharma Lab, Droege Group.
Rohit KhannaTrends & Stories

Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.

Coming soon